10-Undecen-1-ol

CAS No. 112-43-6

10-Undecen-1-ol( —— )

Catalog No. M27520 CAS No. 112-43-6

10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    10-Undecen-1-ol
  • Note
    Research use only, not for human use.
  • Brief Description
    10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.
  • Description
    10-Undecen-1-ol is converted from ricinoleic acid. 10-Undecen-1-ol can be used as a comonomer for the introduction of functional groups.(In Vitro):Cobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn > 10(4) g mol(-1)) based entirely on renewable resources.
  • In Vitro
    Cobalt-catalyzed step growth polymerization of undec-10-en-1-ol and CO affords aliphatic polyesters (Mn 104 g/mol) based entirely on renewable resources.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    platelet-activating factor (PAF)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    112-43-6
  • Formula Weight
    170.296
  • Molecular Formula
    C11H22O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (587.23 mM)
  • SMILES
    OCCCCCCCCCC=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Herbert JM, et al. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. J Pharmacol Exp Ther. 1991 Oct;259(1):44-51.
molnova catalog
related products
  • Pomalidomide-C9-COOH

    Pomalidomide-C9-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based CRBN ligand and linker used in PROTAC technology.

  • Asperuloside

    Asperuloside has anti-inflammatory activity.

  • Longistylin C

    Longistylin A and longistylin C show some cytotoxic effects, with IC(50) values of 0.7-14.7 microM against the range of cancer cell lines.